Genius Test

Genius Test

The Genius Brand4.7 (45 ratings)
Format:Capsule Quantity: 120 Capsule(s) · 30 servings
Goals
$57.99 $1.93 per serving

Product analysis

52 out of 100

Genius Test combines ingredients aimed at testosterone support, with ashwagandha also offering a possible role in stress relief. Several ingredient forms are unspecified, making it harder to compare the formula with preparations that have supporting evidence.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality31

Some plant extracts are identified, but several other forms remain unspecified. That limits a confident judgment of the formula’s quality or how closely its ingredients match particular preparations.

Ingredient Transparency79

All declared ingredient amounts are stated, which helps compare servings. Several forms are omitted, leaving important details about the exact preparations unclear.

Value For Money35

Fenugreek and boron are relatively costly by their respective comparisons. Unresolved comparisons for the other ingredients make the value of the full combination uncertain.

Customer Satisfaction70

The small number of customer ratings is strongly positive. That gives an encouraging early picture of satisfaction but leaves uncertainty about broader experience.

Product Focus65

Testosterone support is the main purpose, with more limited preparation-specific connections to stress, sleep and training. The wider range of goals does not establish that the combined formula improves each of them.

Format
Capsule
Container
120 Capsule(s)
Per serving
$1.93
Customer rating
4.7 · 45 ratings
Report analysis

Goals

Impact
Highest effect
C+ Ingredient FitA+ PathwaysA+ EvidenceA Formulation Logic
Boron · 10 mgAshwagandha · 1000 mg

PrimaVie shilajit has limited hormone-marker evidence in healthy men aged 45–55, and the 500 mg serving matches that study's daily preparation mass. KSM-66 ashwagandha has an exercise-specific testosterone signal, but the 1,000 mg serving exceeds its reviewed exposure without establishing greater benefit. Generic fenugreek cannot borrow Testofen results, and LJ100 lacks verified equivalence to the reviewed tongkat preparation.

How this product is rated for Testosterone Support

Ingredient fit69

Goal-relevant ingredients share the formula with other actives, making its focus broader. The counted amounts partly meet the saved comparisons; small or unresolved amounts limit their contribution.
Goal fit
Goal-relevant ingredients share the formula with other actives, making its focus broader.
Dose adequacy
The counted amounts partly meet the saved comparisons; small or unresolved amounts limit their contribution.

Pathways100

The strongest represented mechanism is testicular testosterone synthesis, subject to the ingredients' evidence limits.
Depth
The strongest represented mechanism is testicular testosterone synthesis, subject to the ingredients' evidence limits.
Breadth
The saved target for mechanism coverage is met; coverage does not establish a measured hormone effect.

Evidence95

Ashwagandha provides the strongest counted evidence comparison, with ingredient-specific population and preparation limits.
Evidence strength
Ashwagandha provides the strongest counted evidence comparison, with ingredient-specific population and preparation limits.
Studied preparation
Preparation matches are incomplete; Fenugreek lack the required match.

Formulation logic94

The counted ingredients satisfy the supplied partner and conflict checks. Amount limitations are described separately.
Partner coverage
The counted ingredients have no unmet partner requirement in the supplied findings.
Conflicts
No configured ingredient conflict was identified.
Effective doses
Some counted ingredients fall short of the minimum amount comparison: Boron.
Study evidence
Boron Disputed 3 studies
Fenugreek Supportive 12 studies
Impact
High effect
C- Ingredient FitC PathwaysB- EvidenceA+ Formulation Logic

Ashwagandha receives a saved stress-fatigue contribution, but the supplied trial did not establish a significant improvement in its standard fatigue outcome. Generic extract mass cannot reproduce the trial's preparation, population or regimen. The larger amount does not establish a general energy boost.

How this product is rated for Energy

Ingredient fit59

Ashwagandha is retained, but the supplied scientific context does not establish routine fatigue relief. Amounts contribute at differing levels.
Goal fit
Ashwagandha is retained, but the supplied scientific context does not establish routine fatigue relief.
Dose adequacy
The ashwagandha amount receives a saved contribution, without establishing a reliable clinical fatigue dose.

Pathways60

The strongest saved contribution concerns stress-fatigue resistance, with limited breadth across the other energy areas.
Depth
The strongest saved contribution concerns stress-fatigue resistance; this does not establish broad daily vitality.
Breadth
Only stress-fatigue resistance reaches the saved coverage requirement; the other energy areas have less or no coverage.

Evidence71

Ashwagandha supplies the leading saved evidence contribution. Its specific nutritional, population or preparation limitations constrain expected benefit.
Evidence strength
Ashwagandha supplies the leading saved evidence contribution, without establishing unconditional improvement in everyday energy.
Studied preparation
The saved check accepts the preparation, but generic ashwagandha mass does not establish the trial's extract or fatigue efficacy.

Formulation logic100

The retained contributors need no missing partner under the supplied checks. No configured conflict was found.
Partner coverage
The retained contributors need no additional partner under the supplied checks; no extra combination benefit is established.
Conflicts
No configured conflict was found; the supplied checks do not assess every possible interaction.
Effective doses
Every retained contributor reaches the saved minimum amount condition; this is distinct from demonstrating an effective fatigue-treatment regimen.
Study evidence
Fitness
Impact
High effect
C- Ingredient FitD+ PathwaysA- EvidenceA+ Formulation Logic
Ashwagandha · 1000 mg

KSM-66 ashwagandha has limited, preparation-specific evidence for supporting resistance-training outcomes. Its contribution depends on repeated use alongside training rather than an acute pre-workout effect. The selected serving is compared with the study exposure without assuming a daily regimen, and a larger amount does not establish greater benefit.

How this product is rated for Fitness

Ingredient fit59

Ashwagandha provides a relevant fitness contribution. The relevant serving amounts reach the saved comparison endpoints; larger amounts do not establish larger benefits.
Goal fit
Ashwagandha contributes to the fitness findings, while other active ingredients make the formula less focused on this goal.
Dose adequacy
The relevant serving amounts reach the saved comparison endpoints; larger amounts do not establish larger benefits.

Pathways52

The strongest contribution concerns muscle protein synthesis. Coverage is concentrated in this area.
Depth
The strongest saved contribution concerns muscle protein synthesis, reflecting the relevant ingredients and serving amounts.
Breadth
Substantial coverage is concentrated in one exercise-related area.

Evidence86

Ashwagandha evidence is specific to the studied root extract and repeated resistance training, without an established acute effect.
Evidence strength
Ashwagandha evidence is specific to the studied root extract and repeated resistance training, without an established acute effect.
Studied preparation
The relevant preparations meet the saved criteria; this does not establish superiority of forms or replicate a complete study regimen.

Formulation logic100

The relevant ingredients have the partners they require, and no configured conflict was identified. Included amounts meet the saved minimum comparison.
Partner coverage
The relevant ingredients can contribute independently or have their required partners present; an additional combination benefit is not established.
Conflicts
No configured ingredient conflict was identified in the supplied findings.
Effective doses
All included ingredients meet the saved minimum amount comparison; this is not proof of benefit from a single serving.
Study evidence
Everyday Health
Impact
Highest effect
C+ Ingredient FitB+ PathwaysA+ EvidenceA+ Formulation Logic
Boron · 10 mgAshwagandha · 1000 mg

Ashwagandha and boron receive saved contributions in stress-related and mineral-metabolism areas. Ashwagandha's stress and insomnia findings depend on the preparation and population, so they do not establish routine broad benefit in unstressed adults. Boron research likewise does not establish general-health improvement or an essential nutrient requirement. Their declared amounts reach the saved endpoints without proving greater benefit at these exposures.

How this product is rated for Everyday Health

Ingredient fit67

The relevant ingredients support the identified roles, with the saved amount comparison determining their contributions.
Goal fit
The relevant ingredients have a role here, while additional actives and links to other goals make the formula less focused.
Dose adequacy
The declared amounts reach the saved comparison endpoints; that does not establish extra benefit above adequate intake.

Pathways80

The saved result recognizes coverage of bone and mineral functions, stress and sleep.
Depth
The saved result places its strongest coverage in stress resilience and sleep.
Breadth
The saved result recognizes coverage of bone and mineral functions, stress and sleep.

Evidence96

Ashwagandha leads the saved finding, but stress-specific research and boron's limited mineral studies do not establish routine broad-health benefit.
Evidence strength
Ashwagandha leads the saved evidence finding; the supplied limitations still restrict what health benefits can be described.
Studied preparation
The saved finding accepts the relevant preparations; it does not establish that a named form or delivery method offers superior benefits.

Formulation logic100

The counted ingredients meet the saved partner and minimum-amount requirements, and no configured conflict is triggered.
Partner coverage
The ingredients counted in the saved result work alone or meet its partner requirements; this does not demonstrate added benefit from combining them.
Conflicts
No configured ingredient conflict was triggered by the supplied facts.
Effective doses
All ingredients counted in this finding reach its saved minimum amount criterion; this is not a proven threshold for health improvement.
Study evidence
Boron Supportive 6 studies
Stress Relief
Impact
High effect
C- Ingredient FitB PathwaysA EvidenceA+ Formulation Logic
Ashwagandha · 1000 mg

Ashwagandha is the ingredient most directly connected to perceived stress in this formula. Several extract trials have reported improvements, but the extract, population and duration affect applicability. The 1000 mg serving does not establish greater benefit than smaller studied amounts, and the rest of this broader formula adds no demonstrated combined stress effect.

How this product is rated for Stress Relief

Ingredient fit59

Relevant stress ingredients sit within a broader formula containing other actives.
Goal fit
Relevant stress ingredients sit within a broader formula containing other actives.
Dose adequacy
The 1000 mg serving provides ashwagandha, but comparison amounts do not establish a proven stress-relief dose.

Pathways77

The strongest represented area is stress-hormone regulation, with effects still limited by the ingredients’ evidence.
Depth
The strongest represented area is stress-hormone regulation, with effects still limited by the ingredients’ evidence.
Breadth
The principal represented areas are stress-hormone regulation, sleep recovery. This does not establish benefits across every aspect of stress.

Evidence95

Ashwagandha extracts have shown reductions in perceived stress, with results depending on the extract, study population and duration.
Evidence strength
Ashwagandha extracts have shown reductions in perceived stress, with results depending on the extract, study population and duration.
Studied preparation
The evaluated preparations match the supplied references, although whole-product and lasting everyday benefits remain unestablished.

Formulation logic100

The evaluated ingredients can contribute independently or have their specified accompanying nutrients represented.
Partner coverage
The evaluated ingredients can contribute independently or have their specified accompanying nutrients represented.
Conflicts
No specified ingredient conflict was found in the supplied combination.
Effective doses
The evaluated ingredients have sufficient amounts for their assigned roles, without establishing a clinically effective dose.
Study evidence
Impact
High effect
C- Ingredient FitC PathwaysB- EvidenceA+ Formulation Logic

KSM-66 ashwagandha may support sleep quality through stress-related effects, with findings drawn from repeated use over weeks. The serving contains 1,000 mg of the identified extract, above the 600 mg daily amount in the highlighted insomnia study; that difference does not establish greater benefit. Ashwagandha supplies the relevant sleep connection in this broadly focused formula. An immediate sedative effect is not established.

How this product is rated for Sleep Support

Ingredient fit59

Ashwagandha supplies the relevant sleep connection, while the many other actives broaden the formula’s focus.
Goal fit
Ashwagandha supplies the relevant sleep connection, while the many other actives broaden the formula’s focus.
Dose adequacy
The KSM-66 amount receives full recognition; exceeding the highlighted study amount does not establish extra benefit.

Pathways60

Stress-related support is the main contribution, with a smaller calming contribution.
Depth
Stress-related support is the strongest area.
Breadth
Only stress-related support reaches the saved coverage target.

Evidence74

The identified KSM-66 extract has preparation-specific sleep evidence from repeated use.
Evidence strength
Ashwagandha provides the strongest relevant evidence here.
Studied preparation
KSM-66 matches the identified extract used in sleep research.

Formulation logic100

Ashwagandha needs no additional required partner, and no listed conflict was found.
Partner coverage
The recognized ingredients have no unmet required partner in the supplied findings.
Conflicts
No listed opposing ingredient conflict was identified.
Effective doses
The ashwagandha amount clears the saved amount threshold.
Study evidence

Ingredients

IngredientAmount per servingScore
KSM-66 (Ashwagandha Root Extract)
1000 mg 85
Primavie
500 mg
Fenugreek (Saponins)
500 mg 73
Quercetin Dihydrate
250 mg
3,3'-Diindolylmethane
250 mg
LJ100 (Eurycoma longifolia Extract)
100 mg
Boron Citrate
10 mg 26
Adults 18–50
Report overview
B- Composition And Label DisclosureA+ Composition And Label Disclosure
+3
Boron · 10 mg OverallScore26
C Active Ingredient Quality & BioavailabilityF Dose, Safety & Label TransparencyF Value
A+ Composition And Label DisclosureF Commercial Price And Usability
Each serving provides 500 mg of fenugreek, with a 50% saponin declaration. The whole-product serving costs about $1.93.
How this ingredient is rated

Composition and Label Disclosure

No additional composition rule was evaluated in this group.

Composition and Label Disclosure100

The available facts record 500 mg of fenugreek and a 50% saponin declaration per serving.
Amount and Label Disclosure
The available facts record 500 mg of fenugreek and a 50% saponin declaration per serving.

Commercial Price and Usability20

A whole-product serving costs about $1.93; that price is for the entire serving.
Commercial Price per Labeled Serving
The listed whole-product serving costs about $1.93.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Acute and Repeated Ashwagandha Supplementation Improves Markers of Cognitive Function and Mood.
    Leonard M; Dickerson B; Estes L; Gonzalez DE; Jenkins V; Johnson S; Xing D; Yoo C; Ko J; Purpura M; Jäger R; Faries M; Kephart W; Sowinski R; Rasmussen CJ; Kreider RB · Nutrients · 2024
    Randomized trial59 participantsBrain Health Cognitive Support Energy forAshwagandha
  2. Effect of ashwagandha (Withania somnifera) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study.
    Rai HP; Mishra DN · Journal of psychopharmacology (Oxford, England) · 2025
    Randomized trial40 participantsBrain Health Cognitive Support forAshwagandha
  3. Efficacy of Withania somnifera supplementation on adult's cognition and mood.
    Remenapp A; Coyle K; Orange T; Lynch T; Hooper D; Hooper S; Conway K; Hausenblas HA · Journal of Ayurveda and integrative medicine · 2022
    Randomized trial60 participantsBrain Health Cognitive Support Productivity Boost forAshwagandha
  4. A clinical assessment of the therapeutic effects of Ashwagandha root extract on cognitive performance, sleep, and fatigue in children aged 6-12 years.
    Saxena A; Lopresti A; Sharif M; Elon N; Suri R; Langade DK · Frontiers in nutrition · 2026
    Randomized trial85 participantsBrain Health forAshwagandha
  5. Efficacy and Safety of Ashwagandha Root Extract on Cognitive Functions in Healthy, Stressed Adults: A Randomized, Double-Blind, Placebo-Controlled Study.
    Gopukumar K; Thanawala S; Somepalli V; Rao TSS; Thamatam VB; Chauhan S · Evidence-based complementary and alternative medicine : eCAM · 2022
    Randomized trial130 participantsBrain Health Sleep Support Stress Relief forAshwagandha
  6. A standardized Ashwagandha root extract alleviates stress, anxiety, and improves quality of life in healthy adults by modulating stress hormones: Results from a randomized, double-blind, placebo-controlled study.
    Majeed M; Nagabhushanam K; Mundkur L · Medicine · 2023
    Randomized trial54 participantsCognitive Support forAshwagandha
  7. Efficacy and safety of ashwagandha root extract in children and adolescents with mild attention-deficit/hyperactivity disorder: a randomized, double-blind, placebo-controlled trial.
    Naik S; Muralidhar G; Rao BS; Agarwal S; Jain M · Journal of medicine and life · 2026
    Randomized trial58 participantsCognitive Support forAshwagandha
  8. Effects of multi-herb and ashwagandha root formulas on stress modulation: a randomized, double-blind, placebo-controlled clinical study.
    McKinney E; Stewart J; Kewalramani R; Singh S · Trials · 2026
    Randomized trial186 participantsEnergy Mood Support forAshwagandha
  9. Efficacy and Safety of Low-Dose Ashwagandha Supplementation on Exercise Endurance: A Randomized, Placebo-Controlled, Double-Blind, Clinical Trial.
    Prajapati H; Satia M; Shah D; Basera I; Shah T · Phytotherapy research : PTR · 2026
    Randomized trialEnergy forAshwagandha
  10. Enhancing healthspan with Ashwagandha (Withania somnifera): a comprehensive review of its multifaceted geroprotective benefits.
    Vittal M; Vinciguerra M · Biogerontology · 2025
    Narrative reviewEnergy forAshwagandha
  11. Safety and Efficacy of Ashwagandha Root Extract on Cognition, Energy and Mood Problems in Adults: Prospective, Randomized, Placebo-Controlled Study.
    Kale S; Lopresti A; Suri R; Garg N; Langade D · Journal of psychoactive drugs · 2026
    Randomized trial120 participantsEnergy Productivity Boost forAshwagandha
  12. A randomized, double blind, placebo controlled study to evaluate the effects of ashwagandha (Withania somnifera) extract on sleep quality in healthy adults.
    Deshpande A; Irani N; Balkrishnan R; Benny IR · Sleep medicine · 2021
    Randomized trial150 participantsEveryday Health Sleep Support forAshwagandha
  13. Effects of Ashwagandha ( Withania somnifera) standardized root extract on physical endurance and VO 2max in healthy adults performing resistance training: An eight-week, prospective, randomized, double-blind, placebo-controlled study.
    Verma N; Gupta SK; Patil S; Tiwari S; Mishra AK · F1000Research · 2024
    Randomized trial80 participantsEveryday Health Fitness Muscle Gain forAshwagandha
  14. Efficacy of Ashwagandha (Withania somnifera [L.] Dunal) in improving cardiorespiratory endurance in healthy athletic adults.
    Choudhary B; Shetty A; Langade DG · Ayu · 2016
    Randomized trial50 participantsEveryday Health Fitness forAshwagandha
  15. Withania somnifera (L.) Dunal as Add-On Therapy for COPD Patients: A Randomized, Placebo-Controlled, Double-Blind Study.
    Singh P; Salman KA; Shameem M; Warsi MS · Frontiers in pharmacology · 2022
    Randomized trial150 participantsEveryday Health forAshwagandha
  16. Effect of Ashwagandha (Withania somnifera) extract on sleep: A systematic review and meta-analysis.
    Cheah KL; Norhayati MN; Husniati Yaacob L; Abdul Rahman R · PloS one · 2021
    Meta-analysis400 participants5 studies pooledEveryday Health Productivity Boost forAshwagandha
  17. Effects of boron supplementation on the severity and duration of pain in primary dysmenorrhea.
    Nikkhah S; Dolatian M; Naghii MR; Zaeri F; Taheri SM · Complementary therapies in clinical practice · 2015
    Randomized trial113 participantsEveryday Health forBoron
  18. Efficacy and safety of tavaborole topical solution, 5%, a novel boron-based antifungal agent, for the treatment of toenail onychomycosis: Results from 2 randomized phase-III studies.
    Elewski BE; Aly R; Baldwin SL; González Soto RF; Rich P; Weisfeld M; Wiltz H; Zane LT; Pollak R · Journal of the American Academy of Dermatology · 2015
    Randomized trialEveryday Health forBoron
  19. The efficacy and safety of tavaborole, a novel, boron-based pharmaceutical agent: phase 2 studies conducted for the topical treatment of toenail onychomycosis.
    Toledo-Bahena ME; Bucko A; Ocampo-Candiani J; Herz-Ruelas ME; Jones TM; Jarratt MT; Pollak RA; Zane LT · Journal of drugs in dermatology : JDD · 2015
    Clinical trial336 participantsEveryday Health forBoron
  20. Boron neutron capture therapy (BNCT) for glioblastoma multiforme: a phase II study evaluating a prolonged high-dose of boronophenylalanine (BPA).
    Henriksson R; Capala J; Michanek A; Lindahl SA; Salford LG; Franzén L; Blomquist E; Westlin JE; Bergenheim AT; Swedish Brain Tumour Study Group · Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology · 2009
    Single-arm trial30 participantsEveryday Health forBoron